Summary:We reviewed gonadal function in 270 patients who underwent bone marrow transplantation (BMT) between 1974 and 1988. Age at transplant ranged from 6 to 54 years (mean 25.6 years). Diagnoses included acute myelogenous leukemia, chronic myelogenous leukemia, aplastic anemia, acute lymphoblastic leukemia, non-Hodgkin lymphoma, Hodgkin's disease and other diagnoses. Effects of patient characteristics on risk of gonadal dysfunction were analyzed by comparing the cumulative probability of developing gonadal dysfunction over time from BMT. Ninety-two percent of the males and 99% of the females developed evidence of gonadal dysfunction. Females were not only more likely to develop elevated gonadotrophin levels than males, but did so earlier after BMT. Odds ratios were calculated to determine potentially important prognostic factors for the development of an elevated gonadotrophin level. Older age at BMT was correlated with an increased risk in the development of elevated gonadotrophin levels. Individuals who received radiation were more likely to develop an elevated FSH level over time than those who had received no preparative radiation treatment. Males were more likely to experience gonadal recovery than females. In those cases that did recover, males tended to recover more quickly after BMT than females. Keywords: gonadal dysfunction; bone marrow transplant; risk; late effectsThe annual number of bone marrow transplants (BMT) has been steadily increasing since 1980. World-wide, BMTs have increased from 500 in 1980 to over 5000 in 1991. 1 The number of transplants at the University of Minnesota has increased over this time, from 43 in 1980 to 200 in 1990. With the increasing utilization of bone marrow transplantation in the last 20 years, several late effects of BMT, particularly endocrine disturbances, have been described.A number of reports in the literature have detailed endocrine dysfunction in children who have undergone BMT. Cyclophosphamide usage has been reported to cause gona- dal damage in both adults and children, and appears to be dose-related and in some instances reversible in males. [2][3][4] Several studies have shown that high-dose chemotherapy and TBI are associated with gonadal dysfunction and failure of gonadal recovery in females. 4,5 These studies also suggest that recovery of ovarian function, but not recovery of testicular function, is more likely to be seen in those who receive fractionated TBI than in individuals who receive single dose TBI. 3,4 The objectives of this retrospective review of individuals who had undergone BMT at the University of Minnesota were to determine the percentage of individuals who developed gonadal dysfunction after bone marrow transplantation, the time to the first documented evidence of gonadal dysfunction after BMT, and the factors associated with this gonadal dysfunction. This study also sought to determine the percentage of individuals who achieved gonadal recovery following dysfunction, the timing of this recovery, and the factors associated with recover...